NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.

Journal Article (Journal Article)

The NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances."

Full Text

Duke Authors

Cited Authors

  • Ettinger, DS; Wood, DE; Aggarwal, C; Aisner, DL; Akerley, W; Bauman, JR; Bharat, A; Bruno, DS; Chang, JY; Chirieac, LR; D'Amico, TA; Dilling, TJ; Dobelbower, M; Gettinger, S; Govindan, R; Gubens, MA; Hennon, M; Horn, L; Lackner, RP; Lanuti, M; Leal, TA; Lin, J; Loo, BW; Martins, RG; Otterson, GA; Patel, SP; Reckamp, KL; Riely, GJ; Schild, SE; Shapiro, TA; Stevenson, J; Swanson, SJ; Tauer, KW; Yang, SC; Gregory, K; OCN, ; Hughes, M

Published Date

  • December 2019

Published In

Volume / Issue

  • 17 / 12

Start / End Page

  • 1464 - 1472

PubMed ID

  • 31805526

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2019.0059


  • eng

Conference Location

  • United States